Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare ...

M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.

The Maplewood, Minnesota-based company said it had net income of 17 cents per share. Earnings, adjusted for one-time gains and costs, were $1.41 per share. The results topped Wall Street expectations.

Reports Q4 revenue $2.074B, consensus $2.05B. “Solventum (SOLV) executed another quarter of solid performance, enabling us to deliver full year ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Nvidia said sales, driven by the chips that power artificial intelligence, rose 78% to $39.3 billion in its latest quarter. Net income rose 80% to $22 billion. Both figures came in ahead of Wall ...

The acquisition of Solventum’s Purification & Filtration business will allow Thermo Fisher Scientific to enhance its ...

Thermo Fisher Scientific is buying Solventum’s purification & filtration unit for $4.1 billion in cash, strengthening its ...

Thermo Fisher Scientific Inc. (Waltham, Mass.) announced that the company has entered into a definitive agreement with Solventum  to acquire Solventum’s ...

Universal Destinations and Experiences will help fund a study for the Sunshine Corridor. The theme park company — part of ...

KBW analyst Meyer Shields maintained a Buy rating on Allstate (ALL – Research Report) today and set a price target of $240.00. The company’s ...